Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 143.88 billion. The enterprise value is 167.42 billion.

Market Cap	143.88B
Enterprise Value	167.42B

Important Dates

The last earnings date was Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Coloplast has 225.17 million shares outstanding. The number of shares has increased by 1.60% in one year.

Current Share Class	207.17M
Shares Outstanding	225.17M
Shares Change (YoY)	+1.60%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	5.66%
Owned by Institutions (%)	23.77%
Float	141.39M

Valuation Ratios

The trailing PE ratio is 31.68 and the forward PE ratio is 24.59. Coloplast's PEG ratio is 2.29.

PE Ratio	31.68
Forward PE	24.59
PS Ratio	5.18
PB Ratio	8.49
P/TBV Ratio	n/a
P/FCF Ratio	28.61
P/OCF Ratio	22.89
PEG Ratio	2.29

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.21, with an EV/FCF ratio of 33.29.

EV / Earnings	36.84
EV / Sales	6.02
EV / EBITDA	19.21
EV / EBIT	22.32
EV / FCF	33.29

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.43.

Current Ratio	0.95
Quick Ratio	0.57
Debt / Equity	1.43
Debt / EBITDA	2.78
Debt / FCF	4.82
Interest Coverage	9.07

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 11.45%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	9.64%
Return on Invested Capital (ROIC)	11.45%
Return on Capital Employed (ROCE)	19.65%
Revenue Per Employee	1.66M
Profits Per Employee	271,429
Employee Count	16,639
Asset Turnover	0.57
Inventory Turnover	2.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.75% in the last 52 weeks. The beta is 0.58, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-24.75%
50-Day Moving Average	711.95
200-Day Moving Average	825.83
Relative Strength Index (RSI)	28.49
Average Volume (20 Days)	245,629

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 27.79 billion and earned 4.54 billion in profits. Earnings per share was 20.17.

Revenue	27.79B
Gross Profit	18.77B
Operating Income	7.50B
Pretax Income	6.49B
Net Income	4.54B
EBITDA	8.43B
EBIT	7.50B
Earnings Per Share (EPS)	20.17

Full Income Statement

Balance Sheet

The company has 729.00 million in cash and 24.26 billion in debt, giving a net cash position of -23.54 billion or -104.52 per share.

Cash & Cash Equivalents	729.00M
Total Debt	24.26B
Net Cash	-23.54B
Net Cash Per Share	-104.52
Equity (Book Value)	16.94B
Book Value Per Share	75.24
Working Capital	-500.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.29 billion and capital expenditures -1.26 billion, giving a free cash flow of 5.03 billion.

Operating Cash Flow	6.29B
Capital Expenditures	-1.26B
Free Cash Flow	5.03B
FCF Per Share	22.33

Full Cash Flow Statement

Margins

Gross margin is 67.52%, with operating and profit margins of 26.99% and 16.35%.

Gross Margin	67.52%
Operating Margin	26.99%
Pretax Margin	23.36%
Profit Margin	16.35%
EBITDA Margin	30.33%
EBIT Margin	26.99%
FCF Margin	18.09%

Dividends & Yields

This stock pays an annual dividend of 22.00, which amounts to a dividend yield of 3.44%.

Dividend Per Share	22.00
Dividend Yield	3.44%
Dividend Growth (YoY)	4.76%
Years of Dividend Growth	12
Payout Ratio	109.07%
Buyback Yield	-1.60%
Shareholder Yield	1.84%
Earnings Yield	3.16%
FCF Yield	3.50%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.13.

Altman Z-Score	5.13
Piotroski F-Score	n/a